Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Ambu A/S: Major Shareholder Announcement

Ambu A/S
Posted on: 21 Nov 17

In pursuance of §29 of the Danish Securities Trading Act (Værdipapirhandelsloven), Ambu A/S hereby reports that we have been informed by N. P. Louis-Hansen Aps that N. P. Louis-Hansen Aps' shareholdings in Ambu have been reduced from 15.2% to 14.9% of the share capital. The voting rights of 6.7% remain unchanged.


Lars Marcher, President & CEO, tel. +45 5136 2490, email:

Company Announcement no. 7 2017_18

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Ambu A/S via GlobeNewswire

Last updated on: 22/11/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.